Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia†: Profile Report

By Curran Monique P.  

Drugs & Aging, Vol. 28, Iss. 10, 2011-10 ,pp. : 843-845

Adis International

Access to resources Recommend Favorite

Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

By Osman Nadir I   Chapple Christopher R   Cruz Francisco   Desgrandchamps François   Llorente Carlos   Montorsi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2085-2096

Informa Healthcare

Access to resources Recommend Favorite

Silodosin: a guide to its use in benign prostatic hyperplasia

By Keating Gillian M.   Curran Monique P.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 4, 2012-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Silodosin, a novel selective α_1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia

By Yoshida Masaki   Homma Yukio   Kawabe Kazuki  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1955-1965

Informa Healthcare

Access to resources Recommend Favorite

A Randomized Crossover Study Comparing Patient Preference for Tamsulosin and Silodosin in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

By Watanabe T   Ozono S   Kageyama S  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 129-142

Field House Publishing

Access to resources Recommend Favorite